is oral glp 1 fda approved Novo Nordisk's Wegovy® pill (oral semaglutide 25 mg, once daily) has just been by the US as the first GLP‑1 receptor agonist for long‑term weight management and CV risk GLP-1 Medications for Weight Loss:

Patients should receive individualized guidance from their healthcare provider regarding injection site selection based on their body composition, comfort level, and ability to properly perform the injection technique

What makes Semaglutide GLP-1 even more appealing is its convenience it requires only a once-weekly dose via subcutaneous injections or a pen injector

W.GreigN

One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes

Ivm Health can help you explore your options and navigate insurance during a free consultation